Exploration of the imidazo[1,2-b]pyridazine scaffold as a protein kinase inhibitor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploration of the imidazo[1,2-b]pyridazine scaffold as a protein kinase inhibitor

Published:2017-01 Issue: Volume:125 Page:696-709
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Bendjeddou Lyamin Z.,Loaëc Nadège,Villiers Benoît,Prina Eric,Späth Gerald F.,Galons Hervé,Meijer Laurent,Oumata Nassima

Funder

Fonds Unique Interministériel

PHARMASEA

TRIAD

Association France Alzheimer

Fondation Jérôme Lejeune

TRANSLEISH

EEC FP7

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference35 articles.

1. Targeting Cancer with small molecule kinase inhibitors;Zhang;Nat. Rev. Cancer,2009

2. The protein kinase complement of the human genome;Manning;Science,2002

3. Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing;Fedorov;Chem. Biol.,2011

4. Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease;Jain;Curr. Drug Targets,2014

5. Activation, regulation, and inhibition of DYRK1A;Becker;FEBS J.,2011

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Probing the variations of synthesis, antimicrobial activity, and optical properties of new lanthanide and transition metal complexes of salicylaldehyde‐dipropylenetriamine ligand;Applied Organometallic Chemistry;2024-05-29

2. Imidazo[1,2-b]pyridazines as inhibitors of DYRK kinases;European Journal of Medicinal Chemistry;2024-04

3. An efficient synthesis of C-6 aminated 3-bromoimidazo[1,2- b ]pyridazines;Synthetic Communications;2023-11-28

4. The Inhibition of DYRK1A Improves Parkinson's Disease by Inhibiting the Phosphorylation of α-Synuclein and Apoptosis of Dopaminergic Neurons;J BIOL REG HOMEOS AG;2023

5. The Importance of the Pyrazole Scaffold in the Design of Protein Kinases Inhibitors as Targeted Anticancer Therapies;Molecules;2023-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3